Perioperative pembrolizumab and lenvatinib for resectable hepatocellular carcinoma: A single-arm, multi-center, phase II trial (NeoLEAP-HCC).

被引：0
|
作者：
Sun, Hui-Chuan
Zhu, Xiao-Dong
Wang, Kui
Xue, Hui
Yang, Ning
Yang, Ying-Cheng
Chen, Yong-Jun
Ye, Feng
Kuang, Ming
Shen, Shun-Li
Huang, Cheng
机构：
[1] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Shanghai, Peoples R China
[2] Fudan Univ, Liver Canc Inst, Zhongshan Hosp, Dept Liver Surg & Transplantat, Shanghai, Peoples R China
[3] Naval Med Univ, Dept Hepat Surg 2, Eastern Hepatobiliary Surg Hosp, Affiliated Hosp 3, Shanghai, Peoples R China
[4] Naval Med Univ, Dept Hepat Surg 5, Affiliated Hosp 3, Eastern Hepatobiliary Surg Hosp, Shanghai, Peoples R China
[5] Shanghai Jiao Tong Univ, Ruijin Hosp, Dept Gen Surg, Sch Med, Shanghai, Peoples R China
[6] Sun Yat Sen Univ, Affiliated Hosp 1, Ctr Hepatopancreatobiliary Surg, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4120
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of the combination of envafolimab and lenvatinib in unresectable hepatocellular carcinoma: a single-arm, multicentre, exploratory phase II clinical study
    Jiang, Yi
    Su, Ke
    Li, Han
    Wang, Chenjie
    Wu, Zhenying
    Chen, Jiali
    Zhang, Zhiyao
    He, Kun
    Han, Yunwei
    INVESTIGATIONAL NEW DRUGS, 2025, 43 (01) : 18 - 29
  • [22] Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
    Ding, Chengzhi
    Guo, Yijun
    Zhou, Yaning
    He, Yi
    Chen, Chunji
    Zhang, Ming
    Guo, Xufeng
    BMC CANCER, 2023, 23 (01)
  • [23] Perioperative tislelizumab plus chemotherapy for locally advanced resectable thoracic esophageal squamous cell carcinoma trial: a prospective single-arm, phase II study (PILOT trial)
    Chengzhi Ding
    Yijun Guo
    Yaning zhou
    Yi He
    Chunji Chen
    Ming Zhang
    Xufeng Guo
    BMC Cancer, 23
  • [24] Stereotactic body radiation therapy in patients with centrally located hepatocellular carcinoma: A retrospective, single-arm, multi-center study
    Zheng, Dan-Xue
    Chen, Yi-Xing
    Sun, Jing
    Hu, Yong
    Yang, Ping
    Zhang, Yang
    Duan, Xue-Zhang
    Zeng, Zhao-Chong
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2024, 46
  • [25] IMMUNIB trial (AIO-HEP-0218/ass): A single-arm, phase II study evaluating safety and efficacy of immunotherapy nivolumab in combination with lenvatinib in advanced-stage hepatocellular carcinoma (HCC).
    Vogel, Arndt
    Siegler, Gabriele Margareta
    Siebler, Jurgen
    Lindig, Udo
    Schultheiss, Michael
    Mueller, Tobias
    Simon, Henry
    Joeckel, Christiane
    Mueller, Daniel Wilhelm
    Al-Batran, Salah-Eddin
    Saborowski, Anna
    De Toni, Enrico N.
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [26] A single-arm, multi-center phase II study of tislelizumab combined with lenvatinib and GEMOX as conversion therapy in potentially resectable locally advanced biliary tract cancer (ZSAB-TransGOLP): A primary analysis.
    Fan, Jia
    Zhou, Jian
    Shi, Guoming
    Huang, Xiaoyong
    Gao, Qiang
    Li, Xiaowu
    Ji, Yuan
    Liang, Fei
    Chen, Yi
    Lu, Pinxiang
    Qiu, Shuangjian
    Ren, Ning
    Shen, Yinghao
    Xu, Yongfeng
    Ding, Zhenbin
    Zhu, Xiaodong
    Sun, Huichuan
    Shi, Yinghong
    Wang, Xiaoying
    Yi, Yong
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 488 - 488
  • [27] Lenvatinib (LEN) combined with tislelizumab (TIS) plus transcatheter arterial chemoembolization (TACE) for unresectable hepatocellular carcinoma (uHCC): A single-arm, phase II clinical trial
    Nong, Xiang
    Zhang, Yu-Mei
    Liang, Jing-Chang
    Xie, Jin-Long
    Zhang, Zhi-Ming
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [28] Regorafenib in older adults with metastatic colorectal cancer: A multi-center, single arm phase II trial
    Badri, Nabeel
    Zittel, Jason
    Baran, Andrea M.
    Dotan, Efrat
    Hubbard, Joleen M.
    Noel, Marcus Smith
    Hezel, Aram F.
    Tejani, Mohamedtaki Abdulaziz
    Mohile, Supriya Gupta
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [29] CAMRELIZUMAB COMBINED WITH LENVATINIB AND RALOX-HAIC FOR HEPATOCELLULAR CARCINOMA (HCC) IN BCLC STAGE B AND C: A PROSPECTIVE, SINGLE-ARM TRIAL (CAL ERA STUDY)
    Zang, Mengya
    Li, Yuanfeng
    Yuan, Guosheng
    Li, Qi
    Hu, Xiaoyun
    Li, Wenli
    Li, Chuanjiang
    Pang, Huajin
    HEPATOLOGY, 2024, 80 : S1967 - S1968
  • [30] Venous infusion chemotherapy (VIC) combined with apatinib and camrelizumab for hepatocellular carcinoma (HCC) in CNLC stage III: A prospective, single-arm, phase II trial.
    Peng, Linhui
    Chen, Tao
    Chen, Yajin
    Xu Yunxiuxiu
    Wang, Jie
    Zhong, Guoping
    Xiao, Zhiyu
    Zhou, Zhenyu
    Ye, Congting
    Li, Yong
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
12345